Cargando…

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease

BACKGROUND: We recently demonstrated a positive effect of berberine on nonalcoholic fatty liver disease patients after 16 weeks of treatment by comparing mere lifestyle intervention in type 2 diabetes patients with berberine treatment, which decreased the content of hepatic fat. However, the potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Xinxia, Wang, Zhe, Zhang, Jinlan, Yan, Hongmei, Bian, Hua, Xia, Mingfeng, Lin, Huandong, Jiang, Jiandong, Gao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024486/ https://www.ncbi.nlm.nih.gov/pubmed/27629750 http://dx.doi.org/10.1186/s12967-016-0982-x

Ejemplares similares

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2022)

Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study
por: Chang, Xinxia, et al.
Publicado: (2015)

Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study
por: Yan, Hongmei, et al.
Publicado: (2013)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2021)

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
por: Yan, Hongmei, et al.
Publicado: (2021)

The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Wei, Xiaoyun, et al.
Publicado: (2016)

Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study
por: Li, Qian, et al.
Publicado: (2016)

DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
por: Zhu, Xiaopeng, et al.
Publicado: (2020)

Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
por: Yuan, Xinlu, et al.
Publicado: (2015)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
por: Chen, Ping, et al.
Publicado: (2021)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation
por: Zhu, Xiaopeng, et al.
Publicado: (2020)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
por: Sang, Chao, et al.
Publicado: (2021)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population
por: Hu, Wen, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
por: Durazzo, Marilena, et al.
Publicado: (2012)

Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese
por: Li, Xiaoming, et al.
Publicado: (2013)

Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells
por: Sun, Yixuan, et al.
Publicado: (2017)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study
por: Wang, Dan, et al.
Publicado: (2016)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease
por: Simpson, Joy, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
por: Huang, Yue Ye, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications
por: Andronescu, Craita Isabela, et al.
Publicado: (2018)

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
por: Yu, Yao, et al.
Publicado: (2018)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
por: Mijangos-Trejo, Alejandra, et al.
Publicado: (2023)

The therapeutic effects of berberine plus sitagliptin in a rat model of fatty liver disease
por: Mehrdoost, Soraya, et al.
Publicado: (2021)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
por: Xu, Yanlan, et al.
Publicado: (2021)

Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
por: Dai, Xianmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_piukr8b0qvjmvasobcsv6uudb5